Replies to post #2407 on Enanta Pharmaceuticals Inc (ENTA)

[DewDiligence]

ENTA’s officers/directors cumulatively owned 12.7% of shares outstanding*, according to p.6 of the annual-meeting proxy in the post I’m replying to.

12.7% is a high equity stake for officers/directors of a company that has been publicly traded for nearly ten years; this is attributable to ENTA’s not having raised capital since the IPO in Mar 2013.

*As of 12/15/22.